Strata Critical Medical Inc Quick Ratio (SRTA) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Strata Critical Medical Inc   (NASDAQ: SRTA)

Strata Critical Medical Inc 's Quick Ratio

SRTA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Strata Critical Medical Inc 's Cash & cash equivalent grew by 80.91 % in the Q3 2026 sequentially, while Current Liabilities decreased, this led to improvement in Strata Critical Medical Inc 's Quick Ratio to 0.92, Quick Ratio remained below Strata Critical Medical Inc average.

Within Medical Equipment & Supplies industry 148 other companies have achieved higher Quick Ratio than Strata Critical Medical Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 863 to 2439.

Explain Quick Ratio?
How much Cash & cash equivalents SRTA´s has?
What are SRTA´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SRTA/financial-strength
https://api.csimarket.com/api/v1/companies/SRTA/fundamentals
https://api.csimarket.com/api/v1/companies/SRTA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
SRTA Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 65.75 %
Y / Y Cash & cash equivalent Change 80.91 %
Quick Ratio MRQ 0.92
SRTA's Total Ranking # 2439
Seq. Current Liabilities Change -1.44 %
Seq. Cash & cash equivalent Change 80.91 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 735
Overall Market # 2439


Quick Ratio Statistics
High Average Low
68.55 15.33 0.32
(Dec 31 2021)   (Mar 31 2021)




Financial Statements
Strata Critical Medical Inc 's Current Liabilities $ 45 Millions Visit SRTA's Balance sheet
Strata Critical Medical Inc 's Cash & cash equivalent $ 42 Millions Visit SRTA's Balance sheet
Source of SRTA's Sales Visit SRTA's Sales by Geography


Cumulative Strata Critical Medical Inc 's Quick Ratio

SRTA's Quick Ratio for the trailling 12 Months

SRTA Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 114.43 %
Y / Y Cash & cash equivalent TTM Growth -25.15 %
Quick Ratio TTM 1.42
Total Ranking TTM # 3939
Seq. Current Liabilities TTM Growth 15.97 %
Seq. Cash & cash equivalent TTM Growth 11.18 %


On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2026 to $45.12 millions, cumulative Quick Ratio decreased to 1.42 below the Strata Critical Medical Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 201 other companies have achieved higher Quick Ratio than Strata Critical Medical Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3766 to 3939.

Explain Quick Ratio?
How much Cash & cash equivalents SRTA´s has?
What are SRTA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 202
Healthcare Sector # 893
Within the Market # 3939


trailing twelve months Quick Ratio Statistics
High Average Low
3.95 1.87 0.05
(Sep 30 2022)   (Sep 30 2019)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Sensus Healthcare Inc   2.53 $ 12.920  Millions$ 5.111  Millions
Beta Bionics Inc   2.48 $ 81.551  Millions$ 32.836  Millions
Irhythm Holdings Inc   2.46 $ 560.719  Millions$ 228.025  Millions
Genedx Holdings Corp   2.38 $ 170.118  Millions$ 71.403  Millions
Apyx Medical Corp  2.37 $ 25.777  Millions$ 10.870  Millions
Atricure Inc   2.23 $ 187.031  Millions$ 83.972  Millions
Vivani Medical Inc   2.22 $ 14.591  Millions$ 6.585  Millions
Electromed Inc   2.19 $ 15.875  Millions$ 7.261  Millions
Inspire Medical Systems inc   1.96 $ 190.803  Millions$ 97.438  Millions
Aethlon Medical Inc   1.91 $ 6.487  Millions$ 3.403  Millions
Merit Medical Systems Inc  1.90 $ 503.551  Millions$ 265.083  Millions
Nephros Inc   1.89 $ 4.546  Millions$ 2.409  Millions
Fractyl Health Inc   1.82 $ 31.515  Millions$ 17.345  Millions
Warby Parker Inc   1.77 $ 287.914  Millions$ 162.226  Millions
Anika Therapeutics Inc   1.68 $ 44.957  Millions$ 26.725  Millions
EBR Systems, Inc.  1.63 $ 85.415  Millions$ 52.539  Millions
Intuitive Surgical Inc   1.60 $ 4,042.500  Millions$ 2,533.000  Millions
Tactile Systems Technology Inc   1.58 $ 75.110  Millions$ 47.499  Millions
Edap Tms Sa  1.56 $ 56.269  Millions$ 36.070  Millions
Neuraxis Inc   1.55 $ 4.477  Millions$ 2.888  Millions
Envista Holdings Corporation  1.42 $ 1,158.800  Millions$ 816.300  Millions
Inogen Inc   1.38 $ 96.840  Millions$ 70.265  Millions
Intelligent Bio Solutions Inc   1.30 $ 5.930  Millions$ 4.578  Millions
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions
Sanara Medtech Inc   1.09 $ 17.788  Millions$ 16.282  Millions
Penumbra Inc  1.09 $ 254.282  Millions$ 233.810  Millions
Koru Medical Systems Inc   1.08 $ 7.364  Millions$ 6.792  Millions
Establishment Labs Holdings Inc   1.06 $ 75.812  Millions$ 71.611  Millions

Date modified: 2026-11-04T15:26:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.